Why you remember names and ski slopes(eople grow older. It's important to ke...),Health
Navigation Links
Why you remember names and ski slopes
Date:11/21/2007
eople grow older. "It's important to keep learning so your synapses stay healthy," Penzes said.
'/>"/>
| Contact: Marla Paul Marla-Paul@northwestern.edu 312-503-8928 Northwestern University Source:Eurekalert |
Related medicine news :
1. Alzheimers Foundation of America to Display Quilt to Remember in Los Angeles
2. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
3. Mediware Names Thomas K. Mann Chief Executive Officer
4. Cleveland-based Health Care Tech Company Within3 Names New CEO
5. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
6. Patient Safety Authority Board of Directors Names Infection Advisory Panel
7. Hooper Holmes Names Chris Behling President of Health & Wellness Division
8. MDMA Names New Director of Federal Affairs
9. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
10. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
11. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
Post Your Comments:
(Date:12/1/2008)...US, Ohio, Dec. 1 Seniors who take ...by Medicare Advantage plans may still realize,sav...y locations will continue,to offer $0 monthly pre...roughout the "gap" or "donut hole" (when beneficia...$4,350 in out-of-pocket costs). HealthMetrix,Res...
(Date:12/1/2008)...se cases, the implant makes it more difficult to t... MONDAY, Dec. 1 (HealthDay News) -- Women who have... later diagnosed with early-stage breast cancer ma...diation treatment known as brachytherapy, accordin...,s such a challenge to take care of these augmente...
(Date:12/1/2008)... American Board of Medical Spec...the certification of physician specialists in the ..., as the organization’s new chief operating ... EVANSTON, Ill. (Business Wire EON) Dec...xperience working in various industries including ...
(Date:12/1/2008)...nary CTA offers a low cost, non-invasive alternati...ents who are suspected of having coronary artery d...oronary artery plaques, according to a study perfo...Philadelphia, PA. , The study included 31 patien...laques that were discovered during coronary CTA. C...
Breaking Medicine News(10 mins):Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2009 Out-of-Pocket Drug Costs 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 3Health News: ABMS Appoints Margaret Jung As New COO 2[0] HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2009 Out-of-Pocket Drug Costs[0] Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer[0] ABMS Appoints Margaret Jung As New COO [0] Coronary CTA: Non-invasive, low cost alternative for 'intermediate risk' patients
...A patient lying in a vegetative state for over 3 y...ill, given to assuage a spell of restlessness//. T...clinical testing. Zolpidem, the name of this slee...n 30 patients during the course of this year, to c...
...Irritable bowel syndrome, by which 15% of American... habits and when medication doesn't help, there's .... Others like constipation, bloating, diarrhea and...ble, limiting some of their day-to-day activities....
...With the death toll rising to over 3500 and an inc...quake that measured 6.2 on scale, Indonesia strugg...uake hit the densely populated area in the south o... the southern coast of Java at 10.53PM late on the...
...A new survey has shown some alarming world statist..., which has indicated// that almost one in five 13...hese figures were made available in the run up to ...No Tobacco Day; on May 31st. This years theme will...
Other Medicine News:Health News:Silence Puts Comfort For Digestive Syndrome 2Health News:Indonesian Earthquake – Story of Destruction, Death and Disease 2(Date:11/26/2008)...06 Subjects , , FRANKLIN, Mass., Nov. 26 /P...etin Board: PLCSF) announced today that it has rec...ministration (FDA) for its U.S. pivotal trial to s... System(TM) and associated therapy in the prevent..., The FDA also approved PLC,s request to expand ...
(Date:11/25/2008)...v. 25 Kleinert Kutz and...d the fifth U.S. hand transplant on Messina, New Y... Jewish Hospital Hand Care Center on Monday, Novem...n and was completed shortly after 9 p.m. in a reco...scom.com/cgi-bin/prnh/20081125/DC48555-a ) , (P...
(Date:11/25/2008)..., Calif., Nov. 25 Proteolix, Inc.,...el therapeutics that target,protein degradation p...announced that data from two ongoing Phase 2 clini...l be presented at the upcoming 50th Annual Meeting...rfilzomib is the first in a new class,of specific...
(Date:11/25/2008)...Nov. 25 Pharmacyclics, I...mpany has completed a Phase 1,clinical trial with...mall-molecule Factor VIIa inhibitor. The trial was...evaluate the safety and pharmacologic effect of,P...ulted in a linear dose,response in the Internatio...
Breaking Medicine Technology:PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Childhood Obesity May Be Leveling Off 20322 1Childhood Obesity May Be Leveling Off 20322 2Childhood Obesity May Be Leveling Off 20322 3Cornell receives federal grants to create fabrics to render toxic chemicals harmless 20319 1Cornell receives federal grants to create fabrics to render toxic chemicals harmless 20319 2Ohio Association of Health Plans Names Pinnacle Awards to Programs That Improve Health Care for Ohioans 20316 1Ohio Association of Health Plans Names Pinnacle Awards to Programs That Improve Health Care for Ohioans 20316 2Techno Savvy Public Awareness Campaign Enables Families to Send a Powerful Message About Childrens Mental Health 20313 1Techno Savvy Public Awareness Campaign Enables Families to Send a Powerful Message About Childrens Mental Health 20313 2[0] PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.[1] Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center[1] Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology[0] Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
... 25, 2007 - VIVUS, Inc.,(NASDAQ: VVUS), a pharmace...mmercialization of novel therapeutic products,ann...mic Parameters,in Obese Diabetic Patients Treated ...vate Practice Setting has been published in the,Am...ns Abstract,book. The abstract is available on the...
...2007 - Elixir,Pharmaceuticals, Inc., today announc...a demonstrating that ghrelin antagonism may be a,p... metabolic,disorders. These data demonstrated a va...reasing body weight, improvements in,blood glucose....,The data were presented in poster sessions on Su...
Other Medicine Technology:VIVUS Announces Abstract Published at American Diabetes Association,Scientific Sessions 2VIVUS Announces Abstract Published at American Diabetes Association,Scientific Sessions 3Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 2Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 3Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting 4...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |